title: Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer.
authors.affiliation: Department of Respiratory Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.
authors.forename: Meng-zhao
authors.initials: MZ
authors.lastname: Wang
authors.forename: Long-yun
authors.initials: LY
authors.lastname: Li
authors.forename: Shu-lan
authors.initials: SL
authors.lastname: Wang
authors.forename: Xiao-tong
authors.initials: XT
authors.lastname: Zhang
authors.forename: Wei
authors.initials: W
authors.lastname: Zhong
authors.forename: Li
authors.initials: L
authors.lastname: Zhang
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib